KR101091376B1 - 세로토닌 수송체(sert) 억제제 - Google Patents

세로토닌 수송체(sert) 억제제 Download PDF

Info

Publication number
KR101091376B1
KR101091376B1 KR1020087013216A KR20087013216A KR101091376B1 KR 101091376 B1 KR101091376 B1 KR 101091376B1 KR 1020087013216 A KR1020087013216 A KR 1020087013216A KR 20087013216 A KR20087013216 A KR 20087013216A KR 101091376 B1 KR101091376 B1 KR 101091376B1
Authority
KR
South Korea
Prior art keywords
phenyl
pyrrolidine
formula
benzyloxymethyl
trifluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020087013216A
Other languages
English (en)
Korean (ko)
Other versions
KR20080064200A (ko
Inventor
크리스토프 그룬드쇼베르
토르스텐 호프만
안드레아스 코블렛트
패트릭 슈니더
Original Assignee
에프. 호프만-라 로슈 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프. 호프만-라 로슈 아게 filed Critical 에프. 호프만-라 로슈 아게
Publication of KR20080064200A publication Critical patent/KR20080064200A/ko
Application granted granted Critical
Publication of KR101091376B1 publication Critical patent/KR101091376B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020087013216A 2005-12-01 2006-11-22 세로토닌 수송체(sert) 억제제 Expired - Fee Related KR101091376B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05111565 2005-12-01
EP05111565.7 2005-12-01
PCT/EP2006/068740 WO2007063009A1 (en) 2005-12-01 2006-11-22 Serotonin transporter (sert) inhibitors

Publications (2)

Publication Number Publication Date
KR20080064200A KR20080064200A (ko) 2008-07-08
KR101091376B1 true KR101091376B1 (ko) 2011-12-07

Family

ID=37686112

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087013216A Expired - Fee Related KR101091376B1 (ko) 2005-12-01 2006-11-22 세로토닌 수송체(sert) 억제제

Country Status (13)

Country Link
US (1) US20070129419A1 (cg-RX-API-DMAC7.html)
EP (1) EP1957450B1 (cg-RX-API-DMAC7.html)
JP (1) JP5020967B2 (cg-RX-API-DMAC7.html)
KR (1) KR101091376B1 (cg-RX-API-DMAC7.html)
CN (1) CN101316816B (cg-RX-API-DMAC7.html)
AT (1) ATE434605T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006319244B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0619154A2 (cg-RX-API-DMAC7.html)
CA (1) CA2631221C (cg-RX-API-DMAC7.html)
DE (1) DE602006007483D1 (cg-RX-API-DMAC7.html)
ES (1) ES2326285T3 (cg-RX-API-DMAC7.html)
IL (1) IL191468A (cg-RX-API-DMAC7.html)
WO (1) WO2007063009A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012051103A1 (en) 2010-10-11 2012-04-19 Theravance, Inc. Serotonin reuptake inhibitors
WO2014152768A1 (en) * 2013-03-15 2014-09-25 Portola Pharmaceuticals, Inc. Cyclohexanediamine compounds and methods for their preparation
CN106459013B (zh) 2014-05-15 2019-10-25 阵列生物制药公司 作为trka激酶抑制剂的化合物及其用途
MA43313B1 (fr) 2015-09-02 2022-06-30 Trevena Inc Aza-hétérocyclique à 6 éléments contenant des composés modulateurs de récepteurs opioïdes delta, et leurs procédés de fabrication et d'utilisation
CN110520129A (zh) * 2017-02-17 2019-11-29 特维娜有限公司 含有5元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
CN110446495B (zh) 2017-02-17 2023-09-05 特维娜有限公司 含有7元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
US20220213061A9 (en) * 2020-02-25 2022-07-07 Tes Pharma S.R.L. Heterocyclic compounds for modulating nr2f6
CN116406268A (zh) 2020-10-27 2023-07-07 特维娜有限公司 δ-阿片样物质调节剂的结晶和无定形形式

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003015784A1 (en) 2001-08-14 2003-02-27 Glaxo Group Limited 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
WO2003042173A1 (en) 2001-11-13 2003-05-22 Schering Corporation Nk1 antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI94339C (fi) * 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
JP2007507504A (ja) * 2003-09-30 2007-03-29 メルク エンド カムパニー インコーポレーテッド フェニルピロリジンエーテル系タキキニン受容体拮抗薬
US7138423B2 (en) * 2004-07-20 2006-11-21 Bristol-Myers Squibb Company Arylpyrrolidine derivatives as NK-1 /SSRI antagonists

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003015784A1 (en) 2001-08-14 2003-02-27 Glaxo Group Limited 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
WO2003042173A1 (en) 2001-11-13 2003-05-22 Schering Corporation Nk1 antagonists

Also Published As

Publication number Publication date
IL191468A (en) 2012-02-29
DE602006007483D1 (cg-RX-API-DMAC7.html) 2009-08-06
EP1957450A1 (en) 2008-08-20
KR20080064200A (ko) 2008-07-08
JP2009517435A (ja) 2009-04-30
EP1957450B1 (en) 2009-06-24
US20070129419A1 (en) 2007-06-07
JP5020967B2 (ja) 2012-09-05
AU2006319244A1 (en) 2007-06-07
CN101316816B (zh) 2011-07-27
CA2631221A1 (en) 2007-06-07
ATE434605T1 (de) 2009-07-15
BRPI0619154A2 (pt) 2011-09-20
ES2326285T3 (es) 2009-10-06
WO2007063009A1 (en) 2007-06-07
CA2631221C (en) 2014-06-03
AU2006319244B2 (en) 2011-07-07
CN101316816A (zh) 2008-12-03

Similar Documents

Publication Publication Date Title
US7528136B2 (en) Prolinamide derivatives as NK3 antagonists
US20220062257A1 (en) 5-ht2a agonists for use in treatment of depression
AU2001273942A1 (en) Pyrrolidine and piperidine derivatives and their use for the treament of neurodegenerative disorders
IL191468A (en) Serotonin transporter (sert) inhibitors, process for their preparation, medicaments containing them and use thereof in the preparation of medicaments for the treatment of anxiety and depression
KR20110010783A (ko) Mri로서의 아릴 케톤
AU2006232871A1 (en) Histamine H3 receptor agents, preparation and therapeutic uses
US8404679B2 (en) Pyrrolidine derivatives as NK2 receptor antagonists
EP2364295B1 (en) 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists
KR101101107B1 (ko) 세로토닌 수송체 억제제 및 뉴로키닌-1 수용체 길항제로 유용한 피페리딘 유도체
PT1749001E (pt) 3-piperidinilisocroman-5-oles como agonistas da dopamina
US7470684B2 (en) Spiropiperidine derivatives as NK3 antagonists
US7501422B2 (en) Prolinamide-tetrazole derivatives as NK3 receptor antagonists

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20141128

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20150930

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20161125

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20170929

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20181202

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20181202

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000